Post job

Immunome executives

Here are further demographic highlights of the leadership team:
  • The Immunome executive team is 25% female and 75% male.
  • 66% of the management team is White.
  • 9% of Immunome management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Immunome?
Share your experience

Rate Immunome's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Scott K. Dessain

Founder

Michael Lefenfeld

Board Member

Purnanand D. Sarma

Board Member

Purnanand D. Sarma's LinkedIn

Purnanand D. Sarma Ph.D. (formerly known as Sarma Duddu) serves as President and Chief Executive Officer at TARIS Biomedical. Dr. Sarma comes to TARIS with more than 15 years of pharmaceutical experience and has been involved in all aspects of the drug delivery business. Most recently, he held the position of General Manager and Vice President of Worldwide Drug Delivery Technologies of CIMA LABS, Inc., a wholly owned subsidiary of Cephalon, Inc (NASDAQ:CEPH). Prior to Cephalon, Dr. Sarma served as Vice President of Pharmaceutical Development at Nektar Therapeutics (NASDAQ:NKTR) (formerly Inhale Therapeutic Systems), a leading drug delivery company based in San Carlos, CA. Prior to Nektar, he worked at SmithKline Beecham Pharmaceuticals, where he focused in the areas of pharmaceutical technology, formulation sciences and product development. Dr. Sarma earned a Ph.D. in Pharmaceutics from the University of Minnesota and a Bachelors degree in Pharmacy from Andhra University in Waltair, India.

Corleen M. Roche

Chief Financial Officer

Michael J. Morin

President and Chief Strategy Officer

Richard A. Baron

Board Member

Sandra G. Stoneman

Chief Legal Officer and General Counsel

Franklyn G. Prendergast

Board Member

John L. Lamattina

Board Member

Matthew K. Robinson

Senior Vice President

Do you work at Immunome?

Does the leadership team provide a clear direction for Immunome?

Immunome jobs

Immunome founders

Name & TitleBio
Scott K. Dessain

Founder

Michael Lefenfeld

Board Member

Immunome board members

Name & TitleBio
Scott K. Dessain

Founder

Michael Lefenfeld

Board Member

Purnanand D. Sarma

Board Member

Purnanand D. Sarma's LinkedIn

Purnanand D. Sarma Ph.D. (formerly known as Sarma Duddu) serves as President and Chief Executive Officer at TARIS Biomedical. Dr. Sarma comes to TARIS with more than 15 years of pharmaceutical experience and has been involved in all aspects of the drug delivery business. Most recently, he held the position of General Manager and Vice President of Worldwide Drug Delivery Technologies of CIMA LABS, Inc., a wholly owned subsidiary of Cephalon, Inc (NASDAQ:CEPH). Prior to Cephalon, Dr. Sarma served as Vice President of Pharmaceutical Development at Nektar Therapeutics (NASDAQ:NKTR) (formerly Inhale Therapeutic Systems), a leading drug delivery company based in San Carlos, CA. Prior to Nektar, he worked at SmithKline Beecham Pharmaceuticals, where he focused in the areas of pharmaceutical technology, formulation sciences and product development. Dr. Sarma earned a Ph.D. in Pharmaceutics from the University of Minnesota and a Bachelors degree in Pharmacy from Andhra University in Waltair, India.

Richard A. Baron

Board Member

Franklyn G. Prendergast

Board Member

John L. Lamattina

Board Member

Philip R. Wagenheim

Board Member

Benjamin Harman

Board Member

Michael Rapoport

Board Member

Michael Rapp

Board Member

Immunome executives FAQs

Zippia gives an in-depth look into the details of Immunome, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Immunome. The employee data is based on information from people who have self-reported their past or current employments at Immunome. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Immunome. The data presented on this page does not represent the view of Immunome and its employees or that of Zippia.

Immunome may also be known as or be related to IMMUNOME INC., Immunome, Immunome Inc. and Immunome, Inc.